CAR-M cell therapy shows promise in preclinical studies
Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.| Multiple Sclerosis News Today
Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.| Multiple Sclerosis News Today
Protecting your energy is crucial in life with chronic illness, says columnist Marisa Zeppieri, so be sure to avoid things that drain you.| Lupus News Today
Columnist Kerry Wong shares highlights from the recent Bridging Autoimmunity: Patient Forum hosted by IMIDeology.| Sarcoidosis News
Columnist Candace Semien writes that living consists of weaving a web of people and circumstances, including the challenges of lupus.| Lupus News Today
Columnist Candace Semien describes the sort of personal surveillance she wants in case she has a lupus flare or other emergency.| Lupus News Today
Professor Tianfu Wu is developing a spleen-specific drug delivery system to suppress lupus-causing immune cells and reduce side effects.| Lupus News Today
Novartis' therapy candidate ianalumab safely and effectively eased disease activity for adults with active Sjögren's in two clinical trials.| Sjogren's Disease News
Being honest about lupus symptoms and challenges helps us be proactive and stay committed to our health, writes columnist Candace Semien.| Lupus News Today
Columnist Candace Semien explains living with lupus by invoking the mysterious and powerful TARDIS, part of the "Doctor Who" television show.| Lupus News Today
While your journey may look different than others, you can still forge your own path with advocacy, columnist Marisa Zeppieri writes.| Lupus News Today
Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.| Lupus News Today
May marks Lupus Awareness Month, and advocates will be joining together to bring attention to the disease to help "Make Lupus Visible."| Lupus News Today
The FDA has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy for treatment-resistant systemic lupus erythematosus (SLE).| Lupus News Today
